Cargando…

A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report

Adverse effects due to use of fibrates often relate to the skeletal muscle, kidneys, or liver. Rhabdomyolysis is a most serious potential adverse effect. We present a case of resumed fenofibrate induced rhabdomyolysis complicated with acute renal failure.

Detalles Bibliográficos
Autores principales: Kiskac, Muharrem, Zorlu, Mehmet, Cakirca, Mustafa, Karatoprak, Cumali, Peru, Celalettin, Erkoc, Reha, Yavuz, Erdinc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696310/
https://www.ncbi.nlm.nih.gov/pubmed/23833382
http://dx.doi.org/10.4103/0253-7613.111912
_version_ 1782275119584903168
author Kiskac, Muharrem
Zorlu, Mehmet
Cakirca, Mustafa
Karatoprak, Cumali
Peru, Celalettin
Erkoc, Reha
Yavuz, Erdinc
author_facet Kiskac, Muharrem
Zorlu, Mehmet
Cakirca, Mustafa
Karatoprak, Cumali
Peru, Celalettin
Erkoc, Reha
Yavuz, Erdinc
author_sort Kiskac, Muharrem
collection PubMed
description Adverse effects due to use of fibrates often relate to the skeletal muscle, kidneys, or liver. Rhabdomyolysis is a most serious potential adverse effect. We present a case of resumed fenofibrate induced rhabdomyolysis complicated with acute renal failure.
format Online
Article
Text
id pubmed-3696310
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36963102013-07-05 A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report Kiskac, Muharrem Zorlu, Mehmet Cakirca, Mustafa Karatoprak, Cumali Peru, Celalettin Erkoc, Reha Yavuz, Erdinc Indian J Pharmacol Drug Watch Adverse effects due to use of fibrates often relate to the skeletal muscle, kidneys, or liver. Rhabdomyolysis is a most serious potential adverse effect. We present a case of resumed fenofibrate induced rhabdomyolysis complicated with acute renal failure. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3696310/ /pubmed/23833382 http://dx.doi.org/10.4103/0253-7613.111912 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Kiskac, Muharrem
Zorlu, Mehmet
Cakirca, Mustafa
Karatoprak, Cumali
Peru, Celalettin
Erkoc, Reha
Yavuz, Erdinc
A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report
title A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report
title_full A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report
title_fullStr A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report
title_full_unstemmed A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report
title_short A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report
title_sort case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696310/
https://www.ncbi.nlm.nih.gov/pubmed/23833382
http://dx.doi.org/10.4103/0253-7613.111912
work_keys_str_mv AT kiskacmuharrem acaseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT zorlumehmet acaseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT cakircamustafa acaseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT karatoprakcumali acaseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT perucelalettin acaseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT erkocreha acaseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT yavuzerdinc acaseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT kiskacmuharrem caseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT zorlumehmet caseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT cakircamustafa caseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT karatoprakcumali caseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT perucelalettin caseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT erkocreha caseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport
AT yavuzerdinc caseofrhabdomyolysiscomplicatedwithacuterenalfailureafterresumptionoffenofibratetherapyafirstreport